UCL Minds
Trial Talk
The Trial Talk Podcast explores how our work at the MRC Clinical Trials Unit at UCL is improving health in the UK and worldwide. In this new series, we will hear from world-leading experts about the studies we carry out. We will get inside trials on cancer, infections, and neurodegenerative diseases, explore how public and patient involvement is shaping our studies, and discover new ways to run smarter studies.
Vizitează neapărat site-ul podcastului și susține-i creatorul: www.mrcctu.ucl.ac.uk
Autor
UCL Minds
Categorie
Site-ul podcastului
Cel mai nou episod
9 oct. 2026
Unde asculți?
Podcasturi în aplicație Replaio Radio În curândPodcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor
Episoade
Episode 2: PediCAP trial: Optimising treatment for children with severe pneumonia 09.10.2026 30:02
Children with community-acquired pneumonia are usually treated with an injectable antibiotic for five days. This often means staying in hospital for the full treatment period, even when they are well enough to go home earlier. The PediCAP trial tested a new approach designed to help children return home sooner while continuing to receive safe and effective care. In this episode, PediCAP team membe...
Episode 9: The ACORD collaboration: Innovative Clinical Trials for Neurodegenerative Diseases 05.08.2026 30:02
ACORD is a pioneering collaboration that brings together experts from a wide range of disciplines to accelerate the development of treatments for neurodegenerative diseases. In this episode, we explore how ACORD works in practice, the innovative methodologies that underpin it, including the multi-arm, multi-stage trial design, and the opportunities it creates for researchers at different stages of...
Episode 8: International Clinical Trials Methodology Conference 2024 roundup - Early Careers Edition 31.10.2024 25:11
At the start of October, lots of the Unit’s clinical trials methodology researchers travelled to Edinburgh, for the 7th International Clinical Trials Methodology Conference (ICTMC). ICTMC is the largest academic-led conference on clinical trials, bringing together trialists from across the globe to present their latest work in trials methodology. This year's conference featured a wide variety of w...
Episode 7: Preventing multidrug-resistant tuberculosis 25.09.2024 32:51
In September 2024, the World Health Organization (WHO) released new guidance on preventative treatment for tuberculosis (TB). Thanks to new evidence from two randomised controlled clinical trials, the WHO now recommends that contacts of people with multidrug-resistant TB take six months of daily levofloxacin. In this episode of the Trial Talk podcast, we find out more about the TB-CHAMP and VQUIN...
Episode 6: The OPTIC study: Patient views on optimising immunotherapy in cancer 01.07.2024 25:24
Optimisation immunotherapy clinical trials investigate ways of reducing the intensity of immunotherapy cancer treatment. This could be beneficial for patients’ quality of life. But these trials can be challenging to run, as patients may be concerned about the impact that reducing the intensity of treatment could have on the cancer. This episode of the Trial Talk podcast focuses on the MRC Clinical...
Episode 5: Patient and Public Involvement (PPI) in clinical trials 04.06.2024 34:44
The MRC Clinical Trials Unit at UCL is committed to actively involving patients and the public in our trials. All our Patient and Public Involvement (PPI) work is overseen by our PPI Group, made up of MRC CTU staff alongside seven patient representatives, with a wide range of experience in different areas. In this episode of the Trial Talk podcast, two members of the Unit’s PPI Group, Richard Step...
Episode 4: Estimands - Answering the right research questions 26.04.2024 21:30
An estimand is a description of the research question a trial seeks to answer, which can help researchers better understand how their study should be designed and analysed. Estimands also provide a clear way to communicate treatment effects to different stakeholders. This episode of the Trial Talk podcast features Principal Research Fellow Brennan Kahan, exploring how triallists could benefit from...
Episode 3: Subgroup analysis - Who benefits most from a treatment? 14.03.2024 28:45
Clinical trial results usually tell us how effective a treatment was on average for the overall group of participants, but a key question for clinicians, patients and policy makers is: which individual patients benefit most from the treatment and which don’t benefit as much? In the latest episode of the Trial Talk podcast, Peter Godolphin and David Fisher discuss a new method for determining how t...
Episode 2: Lessons from UKCTOCS, a large-scale trial in ovarian cancer screening 12.02.2024 26:58
UKCTOCS (UK Collaborative Trial of Ovarian Cancer Screening) is one of the largest screening trials in ovarian cancer. More than 200,000 women from England, Wales and Northern Ireland took part in it, and it ran for almost two decades. Designing and running such a large and lengthy trial came with its own challenges. In this episode, Professor Usha Menon discusses the key challenges that UKCTOCS f...
Episode 1: Careers in TB trials with Andrew Nunn and Sarah Meredith 01.02.2024 28:57
In the first episode of our new Trial Talk series, Hanif Esmail and Conor Tweed take over the microphones to interview Andrew Nunn and Sarah Meredith, who have both recently retired from the Unit, having spent a combined total of 92 years working in the field of tuberculosis (TB). As we celebrate Andrew and Sarah’s long and accomplished careers, we’ll dive into the history of TB clinical trials an...
Episode 10 (part 2): World AIDS Day: Bringing hope through research to young people living with HIV with Lungile Jafta and Gugu 04.12.2023 19:02
Every year on 1st December, we mark World AIDS Day to show solidarity in the fight against HIV and AIDS, and to remember those who have sadly lost their lives. Since the start of the global AIDS epidemic in the 1980s, researchers have made enormous progress towards preventing HIV transmission, and treating those who are living with HIV so that the virus remains suppressed. But while there have bee...
Episode 10 (part 1): World AIDS Day: Closing the gap between adults and children with Anna Turkova and Philippa Musoke 04.12.2023 24:05
Every year on 1st December, we mark World AIDS Day to show solidarity in the fight against HIV and AIDS, and to remember those who have sadly lost their lives. Since the start of the global AIDS epidemic in the 1980s, researchers have made enormous progress towards preventing HIV transmission, and treating those who are living with HIV so that the virus remains suppressed. But while there have bee...
Episode 9 (part 4): Octopus: Involvement of people affected by MS with Susan Scott 10.11.2023 20:03
Octopus is a new clinical trial for people living with progressive multiple sclerosis (MS), which is designed and run by the MRC Clinical Trials Unit at UCL. Thanks to its multi-arm multi-stage platform design, Octopus has the potential to transform the way treatments for progressive MS are tested. The trial is now open in the UK and will be recruiting participants for the next few years. The podc...
Episode 9 (part 3): Octopus: The patients’ experience with Dawn Lyle and Matthew Justin 02.11.2023 24:05
Octopus is a new clinical trial for people living with progressive multiple sclerosis (MS), which is designed and run by the MRC Clinical Trials Unit at UCL. Thanks to its multi-arm multi-stage platform design, Octopus has the potential to transform the way treatments for progressive MS are tested. The trial is now open in the UK and will be recruiting participants for the next few years. The podc...
Episode 9 (part 2): Octopus: Introducing the trial with Jeremy Chataway 26.10.2023 24:11
Octopus is a new clinical trial for people living with progressive multiple sclerosis (MS), which is designed and run by the MRC Clinical Trials Unit at UCL.Thanks to its multi-arm multi-stage platform design, Octopus has the potential to transform the way treatments for progressive MS are tested. The trial is now open in the UK and will be recruiting participants for the next few years. The podca...
Episode 9 (part 1): Octopus: The multiple sclerosis landscape with Jeremy Chataway, Dawn Lyle and Matthew Justin 19.10.2023 17:21
Octopus is a new clinical trial for people living with progressive multiple sclerosis (MS). Thanks to its multi-arm multi-stage platform design, Octopus has the potential to transform the way treatments for progressive MS are tested. The trial is now open in the UK and will be recruiting participants for the next few years. The podcast mini-series will explore the trial from different perspectives...
Episode 8: Optimising treatments with the new MAMS-ROCI design 20.09.2023 24:29
Innovative platform designs present an opportunity to run faster and more efficient clinical trials. Clinical trials methodology is a research area that looks at how to improve the design, conduct, and analysis of clinical trials. It focuses on developing and implementing new methods to help run trials faster and more efficiently, that will ultimately accelerate the discovery of new treatments. In...
Episode 7: STAMPEDE (part 3): Impact and legacy 12.09.2023 23:24
STAMPEDE is a long-running trial in advanced prostate cancer, in which nearly 12,000 men have taken part. Thanks to its multi-arm multi-stage platform design, STAMPEDE has tested many different treatments and directly led to improvements in the standard of prostate cancer care several times. This Trial Talk podcast mini-series will explore the trial’s journey from its inception in the early 2000s...
Episode 7: STAMPEDE (part 2): The role of the patient voice 12.09.2023 18:01
STAMPEDE is a long-running trial in advanced prostate cancer, in which nearly 12,000 men have taken part. Thanks to its multi-arm multi-stage platform design, STAMPEDE has tested many different treatments and directly led to improvements in the standard of prostate cancer care several times. This Trial Talk podcast mini-series will explore the trial’s journey from its inception in the early 2000s...
Episode 7: STAMPEDE (part 1): A new era for prostate cancer research 16.08.2023 18:04
STAMPEDE is a long-running trial in advanced prostate cancer, in which nearly 12,000 men have taken part. Thanks to its multi-arm multi-stage platform design, STAMPEDE has tested many different treatments and directly led to improvements in the standard of prostate cancer care several times. This Trial Talk podcast mini-series will explore the trial’s journey from its inception in the early 2000s...
Episode 6: The REFINE trial: how can we improve the way we give cancer immunotherapy? 18.07.2023 16:58
Immunotherapy drugs fight cancer by helping the immune system recognise and attack cancer cells. These drugs have revolutionised cancer treatment over the last decade, improving survival for many people with different types of cancer. However, researchers are still unsure of the best way to give immunotherapy, which can come with unpredictable side effects. In this episode, Clinical Fellow Sophie...
Episode 5: How can clinical trials make the most of healthcare systems data? 27.06.2023 25:40
Running a clinical trial means collecting a lot of data from the trial participants. But some of this data might be collected and stored in healthcare systems, as well as in clinical trial case report forms. What if we could avoid this doubling up, save time and resources, improve recruitment and reduce missing data? In this episode we explore the opportunities and challenges of using healthcare s...
Episode 4: Neonatal infections (part 2): How the NeoSep1 trial will help treat sick newborns 12.06.2023 21:14
Neonatal sepsis is a life-threatening infection that affects up to 3 million babies per year globally. In an effort to identify better treatments, the NeoSep1 clinical trial evaluates new antibiotic combinations for newborn babies with sepsis. To learn more about the trial, we speak to Adrie Bekker and Cristina Obiero, principal investigators of the trial in South Africa and Kenya, Reenu Thomas, a...
Episode 4: Neonatal infections (part 1): The NeoOBS study and the global challenge of neonatal sepsis 22.05.2023 23:53
214,000 newborn babies die of sepsis caused by infections that are resistant to antibiotics every year. This is a major problem worldwide, but disproportionally affects low- and middle- income countries. Reenu Thomas and Adrie Bekker, two neonatologists from South Africa, and Francesca Schiavone, clinical project manager at the MRC CTU at UCL in London, discuss the challenges of treating neonatal...
Episode 3: The STREAM2 trial - how should we treat multi-drug resistant tuberculosis? 24.03.2023 20:00
For World TB Day, this episode explores the global burden of tuberculosis (TB) and how growing antibiotic resistance can complicate treatment options. Andrew Nunn, a Professor of Epidemiology, discusses his work on the STREAM2 trial, which investigated how treatment for multi-drug resistant TB could be shortened and made more acceptable for patients. Further information is available on the STREAM...
Podcasturi asemănătoare
Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice